Clostridium Difficile Colitis Case Study
explanatory Essay
979 words
“Clostridium Difficile are the bacteria that can cause irritation or swelling of the large intestine, or colon. The inflammation caused by this bacteria is known as colitis.
Inflammation further causes diarrhea, fever, and abdominal cramping” (WebMD, C. Diff.
Overview 2015). Put it all together and you get Clostridium Difficile Colitis.
In 1973, John G. Bartlett began to see the connection between hospital diarrhea cases and colitis. He recognized articles with series of cases including deaths from various places. Bartlett figured “the pathological course of this illness was a severe inflammatory process with and without pseudomembranes, which involved the large intestine”(Oxford Journal, clinical infectious diseases 2014). 1975 Bartlett mobilized
…show more content…
In this essay, the author
- Describes how they led a team at tufts university school of medicine and its va hospital.
- Describes the term cecum, or pouch connected to the junction of the small and large intestines.
- Explains that difficile played the pathogenic role in the disease.
- Explains that over 8 in 10 cases occur in people over the age of sixty-five.
- Explains that an antibiotic is at risk of developing c. difficile infection, depending on the antibiotic of choice.
- Explains that colon inflammation is caused by a disruption of the healthy colon.
- Recommends placing a friend or family member with c. diff. in an isolated room or with another patient of the same infection. hand washing is critical to precluding the diffusion of contamination.
- Explains that there are more than two million cases of clostridium difficile colitis per year.
“The first step in the discovery process was adapting the hamster model of antibiotic-associated colitis. This was accomplished by demonstrating the pathological similarities, then the relationship to clindamycin exposure, and finally the beneficial effect of vancomycin treatment”( Oxford Journal, clinical infectious diseases 2014). The
Hamster model progressed the studies on treatments for the disease and set in motion the process of identifying the caustic microorganism. “They identified the caustic microorganism two years later by first discovering a toxin-producing clostridium in the cecum; or pouch connected to the junction of the small and large intestines; of infected hamsters”(Oxford Journal, Clinical infectious diseases 2014). The disease was originally labeled incorrectly as C. sordellii, however in 1978, Bartlett corrected them that C. difficile in fact played the pathogenic role in the disease. Lastly the discovery of the cytotoxin assay was an absolute breakthrough that led to unraveling the Clostridium
Difficile toxin story.
Clostridium Difficile Colitis 4
The symptoms for Clostridium difficile colitis are horrible. They include bloody
Related
- explanatory
- analytical
- argumentative
- Ulcerative Colitis Essayexplanatory essayHow can the Disease Extent be divided? Ulcerative colitis progresses from the rectum and moves proximally. Distal disease refers to inflammation that is limited to the rectum (proctitis) or rectum and sigmoid colon. Here it is referred to as proctosigmioditis.
In this essay, the author
- Explains that ulcerative colitis progresses from the rectum and moves proximally. distal disease refers to inflammation that is limited to the
- Explains that the immediate management of the condition is to resuscitate the patient. hydrocortisone can be commenced through the cannula.
- Explains aminosalicylates are the first line of treatment for mild to moderate ulcerative colitis. they reduce inflammation and can be taken orally, as a suppository or as an enema.
- Explains that azathioprine is an immunosuppressant which reduces inflammation. it can be taken orally and the dose will vary with severity of symptoms.
- Explains that surgical complications can be split into abdominal, stoma, and pouch complications.
- Describes the complications of ulcerative colitis, including primary sclerosis cholangitis, toxic mega colon and bowel cancer.
- Explains that the management of primary sclerosing cholangitis is limited because there is no curative medical therapy.
- Explains that gas becomes trapped in the large intestinal and causes it to swell and if left to progress it can be life-threatening.
- Explains that ulcerative colitis patients have an increased risk of developing bowel cancer — the 10 year risk is 1 in 509, and the risk after 30 years is 1. patients should be screened by colonoscopy every few years to check no neoplastic changes.
- Explains that osteoporosis is a common complication of ulcerative colitis. it causes decreased bone mass and makes them more prone to fractures.
- Explains that ulcerative colitis is a chronic condition with significant relapses, and mortality. a norwegian study showed that after 10 years the colectomy rate was 9.8%.
- Explains that ulcerative colitis is a fairly common disease with significant symptoms that affect the patient's quality of life. surgery is curative.
- Advises that patients with ulcerative colitis should be examined by a gastroenterologist to rule out differential diseases.
- Explains that steroid use for more than 12 weeks can cause osteoporosis, hypertension, diabetes, and weight gain.
- Explains the use of an artificial antibody that targets the protein tnf-alpha, which the immune system uses to stimulate inflammation.
- Explains that surgical removal of the colon is the curative treatment of ulcerative colitis.
- Describes the symptoms of sclerosing cholangitis, which causes inflammation, fibrosis and stricture formation of the intra and extra hepatic ducts.
- Explains how intravenous fluids, antibiotics and steroids can be used to treat haustra loss in toxic megacolon. in severe cases, a colectomy may be performed.
2159 wordsRead More - Physiology Of Crohn's Diseaseexplanatory essayIntroduction Crohn’s disease is a chronic inflammatory condition of the gastrointestinal tract that belongs to a group of conditions known as Inflammatory Bowel Diseases (IBD). Crohn’s disease is defined as a transmural inflammation with skip lesions that can affect the gastrointestinal tract from mouth to anus (Mulder, Noble, Justinich, & Duffin, 2013). In Crohn’s disease the immune system attacks the gastrointestinal system and can cause the digestive tract to be chronically inflamed. Crohn’s disease has a variety of symptoms that include abdominal discomfort, diarrhea, rectal bleeding, fever, and weight loss. Crohn’s disease can also affect the joints, skin, eyes, and cause kidney stones, gallstones and other ailments (Warner & Barto, 2007).
In this essay, the author
- Explains that crohn's disease is a chronic inflammatory condition of the gastrointestinal tract that belongs to the group of conditions known as inflammatory bowel diseases (ibd).
- Explains that crohn's disease can involve any area of the gastrointestinal tract and its symptoms are determined by which area is affected.
- Explains the three types of crohn's disease: inflammatory, fistulizing, and fibrostenosing.
- Explains that there are five types of crohn's disease, together with their presenting symptoms.
- Explains that crohn's disease can affect any part of the gastrointestinal tract, from the mouth to the anus.
- Explains that crohn's disease is more prevalent among adolescents and young adults between the ages of 15 and 35. hereditary, genetics, and/or environmental factors play a role in the disease.
- Explains that crohn's disease is diagnosed based on the patient’s clinical history and physical examination along with radiologic, endoscopic, and laboratory testing.
1361 wordsRead More - The Summer of SARSexplanatory essayThe problem with the illness was that the speed of research to understand the causative agent and the efforts to contain the illness was slower than the spread [of] disease up to this point. Ne...
In this essay, the author
- Explains that the summer of 2003 would have been just another summer spent with family and friends except for the introduction of a new viral respiratory illness called sars or severe acute respiratory syndrome.
- Explains that as the date for departure from lax drew closer, more devastating reports of the rapid and deathly effects of sars were gathered by the who.
- Explains that the speed of research to understand the causative agent and the efforts to contain the illness was slower than the spread of disease.
- Explains that the who advised against traveling to heavily infected areas, including taiwan, due to the uncertainty associated with sars. they bought boxes after boxes of facemasks, gloves, antibacterial soap, alcohol based hand-rubs and instant hand sanitizers.
- Explains that taiwan was alarmed by the new illness called sars. people sported their facemasks proudly and not as a fashion faux pas. temperature checks were used as the first line of detection.
- Explains that the awareness of sars was high throughout the world. the surveillance and temperature checks proved to be sensitive, with suspected cases rapidly detected, reported and investigated according to standard case definition.
- Explains that sars is caused by a previously unrecognized coronavirus, but information regarding it is still scarce.
- Explains who's "severe acute respiratory syndrome (sars)-multi-country outbreak-update," march 16, 2003, (accessed april 24, 2005).
- Explains who's "severe acute respiratory syndrome (sars)-multi-country outbreak-update" and "update 61-who extends its sars related travel advice to all of taiwan province, china."
938 wordsRead More - Mycobacterium Tuberculosis Essayexplanatory essayWith discovery of the cause of TB, focus turned to treatment and prevention. A breakthrough came in 1944, when the disease became curable with streptomycin, an antibiotic discovery attributed to American Selman Waksman and his fellow researchers.3 Antibiotic discoveries pertaining to TB were regular for the 20 years following.4
In this essay, the author
- Analyzes how physician robert koch introduced and described the infectious agent causing tuberculosis (tb), previously thought to be an inherited condition.
- Explains that tb became curable with streptomycin, an antibiotic discovery attributed to american selman waksman and his fellow researchers. antibiotic discoveries were regular for the 20 years following.
- Explains that bacteria are not impartial to the process of natural selection, and m. tuberculosis evolved resistance. an appearance on a new epidemic brought tb back into the limelight.
- Opines that despite advances, the disease persists, concentrated in poor and developing regions, and evolution of a form of m. tuberculosis resilient to all currently used medicines threatens the efforts for eradication.
- Explains that m. tuberculosis is a pulmonary infection that is transmitted via sneezing or spitting. it is airborne, but is also possible via sexual intercourse or skin lesions.
- Explains that tb is interesting, although disturbing, because one can breathe in the particles from the environment, become infected, but be unaware of the infection.
- Explains that mycobacterium tuberculosis must make its way into a host organism in order to survive, and cause illness in the host. it thrives in oxygen rich environments, hence the common localization of infection to the lungs.
- Explains that m. tuberculosis bacteria can survive outside of the host for long-term survival. the duration of survival on dry nonliving surfaces ranges from one day to four months.
- Explains that environmental factors, the infected, and the person exposed determine the outcome with respect to tb infection.
- Explains that tuberculosis is second only to hiv/aids as a leading cause of death globally, but distribution is disproportionate throughout the world, with the highest rates of the disease belonging to the eastern hemisphere's poorer regions.
- Analyzes how koch's discovery of m. tuberculosis in 1882 led to a decline in tb-related deaths. the hiv/aids epidemic and drug resistant strain of the bacterium made the disease an easy catch.
- Explains that treatment and control strategies created by organizations such as who and implemented globally have led to a fatality rate decline of 45% between 1990 and 2012.
- Explains that active tb is present in a third of the world's people. there are variable reports with respect to the risk of becoming ill with the latent infection.
- Explains that a person afflicted with active tb coughs, sending infectious particles into the surrounding air. these particles are droplet nuclei that carry the bacteria m. tuberculosis.
- Explains that tb is a global health issue, and the pathogen evades the immune defenses.
- Explains the role of macrophages in the innate immune response.
- Explains that the prr tlr2 of the alveolar macrophage cell membrane recognizes the cell wall glycolipoprotein on m. tuberculosis.
- Explains that the prr tlr9 molecule recognizes a pathogen by specific sequences in the pathogenic dna, the mamp. its interaction produces cytokines and chemokines in an inflammatory immune response.
- Explains that the immune response generated by macrophages and subsequent action by t cells, specifically cd4+ and cd8+ types, can keep the infection under control, but does not rid the body of the pathogen entirely.
- Explains that the two cell death mechanisms have opposing functions. apoptosis kills the invading pathogen, while necrosis is oppositional.
- Explains that the prr cd209 is found on the cell membrane of dendritic cells and recognizes bacterial cell wall products. interleukin 10 is anti-inflammatory because it inhibits macrophages.
- Explains that in active tb, anti-inflammatory mediators act in opposition to the action of proinflammatory cytokines in the immune response.
- Explains that numerous studies have been carried out using mice as animal models of the human tb disease.
- Explains that latent tb is asymptomatic and not infectious, but requires management due to the capacity of the bacteria to transform to active form. the duration of treatment ranges from three months to nine months.
- Explains that treatment of tb disease, that is, the active bacteria, currently consists of administration of drug isoniazid, rifampin, and ethambutol or pyrazinamide.
- Explains that the multi-drug-resistant strain of m. tuberculosis is unaffected by isoniazid and rifampin and requires treatment with a combination of less commonly used drugs.
- Explains that a vaccine for tb called bacilli calmetter-guerin uses mycobacterium bovis, which is attenuated and does not cause infection, simply priming the immune system.
- Opines that the world is on track to fulfill the set goals for tb eradication, with a 45% decrease in rates since 1990.
3160 wordsRead More - Diverticular Disease: What is the difference between diverticulosis and diverticulitis?explanatory essayWhen pockets develop in the wall of the colon, this is called diverticulosis. The pockets that form are called diverticula; the pockets pick up fecal matter as the body’s waste is propelled through the colon.
In this essay, the author
- Explains the difference between diverticulosis and diverticulitis, stating that there is no inflammation, and with the second, there are no symptoms.
- Explains why diverticula form on the colon wall, but it is believed by the medical community that the pouches form due to elevated pressure inside
- Explains the causes of diverticulitis are thought to be due to internal pressure in the colon.
- Explains that diverticulosis is often found during routine screening exams. the pain of diverticulitis mimics pelvic inflammatory disease, appendicitis, ischemic colitis, colon or ovarian cancer.
594 wordsRead More - Clostridium Difficileanalytical essayAmong hospitalized patients around the world, Clostridium difficile is the primary source of infectious diarrhea. Previously, continuously unbalanced intestinal microbiota, usually due to antimicrobials, was deemed a precondition of developing the infection. However, recently, there have been alterations in the biology from virtually infecting the elderly population exclusively, wherein the microbiota in their guts have been interrupted by antimicrobials, to currently infecting individuals within of all age groups displaying no recent antimicrobial use. Furthermore, recent reports have confirmed critical occurrences among groups previously assumed to be of minimal risk—pregnant women, children, and individuals with no previous exposure to antimicrobials, for instance. Unfortunately, this Gram-positive, toxin-producing anaerobic bacterium is estimated to cost US critical care facilities $800 million per year at present, suggesting the need for effective measures to eliminate this nosocomial infection (Yakob, Riley, Paterson, & Clements, 2013).
In this essay, the author
- Explains that clostridium difficile is the primary source of infectious diarrhea among hospitalized patients around the world.
- Explains that c. difficile infection (cdi) is a dangerous healthcare-associated infection and growing burden with the appearance of more potent strains in the early 2000s.
- Analyzes how a new strain of c. difficile, titled "north american pulsed-field gel electrophoresis type 1" (nap1), is partially responsible for this elevated incidence and increased acuteness of illness.
- Explains that c. difficile spores can exist in the environment for months or years and can be found on various surfaces within healthcare facilities.
- Explains that the biological characteristics of c. difficile infection remain indeterminate in the pediatric population.
- Explains that c. difficile is becoming more and more recognizable as a substantial co-morbid factor in well-known pediatric inpatient populations.
- Opines that prior antimicrobial use is the most essential risk factor for c. difficile infection. diminishing antibiotic use, such as surgical antibiotic prophylaxis, is vital in lessening the risk.
- Opines that epidemiology, pathogenesis, treatment, and prevention of c. difficile remain unanswered, citing studies predating the appearance of the prevalent strain.
- Explains that the rate of acquisition of c. difficile throughout hospitalization is relative to the length of stay and can be as high as 40% after 1 month. increasing rates should stimulate additional exploration and prevention measures.
- Explains that antimicrobial stewardship has been proven effective in the prevention of nosocomial infections, but supplementary procedures must be employed to achieve optimal success.
- Explains clorox healthcare bleach germicidal wipes, which are approved by the environmental protection agency, are an important supplement to environmental cleaning, but must be used correctly to be effective.
- Explains that the sterilray far-uv disinfection wand is an innovative environmental disinfection tool that destroys c. difficile swiftly spores and other healthcare-associated pathogens
- Explains that the proposed study design is a prospective multiple-crossover trial due to several advantages, including the fact that each crossover patient functions as his or her own control. case control studies are observational because no intervention or interference is attempted.
- Explains that the main outcome (dependant variable) is the reduction of c. difficile. the main predictor variables are clorox healthcare bleach germicidal wipes and the sterilray disinfection wand device.
- Explains that the study population would include approximately 1,500 pediatric patients in three icus. the primary outcome would be the reduction of c. difficle and is a continuous variable.
- Explains that two observers will examine the practices of health care workers in each icu to measure compliance with disinfection practices. the observations will be disseminated uniformly over eight months.
- Concludes that c. difficile contaminates medical equipment and devices through fecal shedding or by way of contaminated hands of patients or healthcare professionals.
- Recommends clorox healthcare bleach germicidal wipes and sterilray disinfection wands to eliminate the devastating burden of c. difficile infection.
- Cites carrico, r. m., archibald, l. k. bryant, e. garcia, j. g. gould, c.
- Describes the clinical practice guidelines for clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of america (shea) and the infectious diseases society (idsa).
- Explains kim, smathers, prasad, leckerman, coffin, and zaoutis, epidemiological features of clostridium difficile-associated disease among inpatients at children's hospitals in the united states, 2001-2006.
- Describes mills, chan, a.-w., wu, vail, guyatt, and altman, d.
- Evaluates a hand-held far-ultraviolet radiation device for decontaminating clostridium difficile and other healthcare-associated pathogens.
- Describes the future research needs for prevention and treatment of clostridium difficile infection.
- Explains orenstein, aronhalt, mcmanus, & fedraw, l. a. (2011), a targeted strategy to wipe out clostridium difficile.
- Describes the five years experience of clostridium difficile infection in children at uk tertiary hospital.
- Analyzes tamma, p. d., and sandora t. j. (2012). clostridium difficile in children: current state and unaswered questions.
- Explains that clostridium difficile exposure as an insidious source of infection in healthcare settings: an epidemiological model.
- Describes zilberberg, tillotson, and mcdonald's findings on clostridium difficile infections among hospitalized children.
2781 wordsRead More - Racial/Ethnic Disparities In Health Care Receipt Among Male Cancer Survivorsargumentative essayThe colon is divided into four fragments: The ascending, descending, transverse, and additionally the sigmoid colon. At the point where the small intestine empties into the colon is a large pouch, called the cecum. Extending from the cecum a little underneath this point is a slender tubular sac, the appendix.
In this essay, the author
- Explains that colon cancer is a class of diseases categorized by out of control cell development.
- Explains the symptoms of colon cancer, including diarrhea, constipation, blood in the stool, abdominal discomfort, loss of appetite, shortness of breath, weight loss for no known reason, constant fatigue, nausea, vomiting, and pelvic pain.
- Describes the colon as a portion of the digestive tract positioned between the rectum and the small intestine.
- Explains that people with no family histories of colon cancer are at risk for developing polyps in the colon.
- Explains that prior research has found black–white differences in stage-specific colorectal cancer survival rates, recommending disparities in the management of cancer.
- Argues that racial distinctions in risk factors, detection, prevention, and treatment contribute to increased mortality rates among blacks.
- Explains that a colonoscopy is done to distinguish the abnormal mass in the colon, while chemotherapy can be given after surgery to eliminate the cancerous polyps.
- Concludes that racial/ethnic disparities in health care receipt among older male cancer survivors persisted even after adjusting for sociodemographic, healthcare access, and medical need factors.
1818 wordsRead More - Treating Crohn’s Diseaseargumentative essayThis article is a clinical trial, which investigates the formation of antibodies against infliximab when treating Crohn’s disease. It determines that those who have an initial reaction to infliximab already have a high amount of infliximab antibodies in their system and as a result they would not react as well to the treatment for an extended period of time. The aim to gauge the consequence of infliximab antibodies on the treatment of Crohn's disease was achieved by establishing the concentrations of infliximab and infliximab antibodies in patients, also taking note of the patients in which the infusion caused a negative affect. The research pays particular attention to data analysis of the concentration of infliximab and infliximab antibodies in the patients, it is useful as a accessory source, whilst it focuses on the effectiveness as a result of these antibodies, it does not go into detail on the effectiveness of infliximab therapy on the symptoms of Crohn's disease.
In this essay, the author
- Describes a clinical trial that investigates the formation of antibodies against infliximab when treating crohn's disease.
- Explains that the trial is limited by the small number of patients undertaking it, hence, a more extensive trial would be recommended. the source corroborates with other articles found as they often mention the formation of antibodies, which hinder the treatment.
- Explains that this source investigates patients with crohn's disease who had to increase their infliximab dosage due to a lack of continued response.
- Explains that the source aims to determine whether intensification of infliximab treatments would be effective and safe in treating patients with crohn's disease who have a loss of response to the treatment.
- Describes the details of patients who are undergoing an intensified treatment of infliximab in terms of the short-term efficacy, long-lasting efficacies, and safety, as well as the management techniques employed.
- Explains that this article addresses the long-term effectiveness of infliximab in treating crohn's disease.
- Opines that this article would help to form the basis of investigation into the research topic as it includes data pertaining to the effectiveness of infliximab in treating crohn's disease.
- Explains that s undergo a trial to determine the required subsistence of infliximab to sustain clinical remission for patients with crohn's disease.
- Explains that the trial focuses on three different methods of dosage as explained previously, although more testable methods and dosages exist, this range keeps it manageable while still giving sufficient data.
- Concludes that the conclusions drawn from this article are useful for the research topic, as many contrasts were made between the placebo group and the groups being given consistent dosages.
- Evaluates the efficacy of the combination of seton drainage with infliximab for treatment of complex perianal fistulas, which are a main symptom of crohn's disease.
- Explains that the source is highly useful in this research topic as it goes into detail on the treatment of perianal fistulas, a symptom of crohn's disease.
- Explains that this source is limited as it focuses solely on adolescents and has a limited number of medical records analysed. it is well referenced with no conflict of interests acknowledged, which supports its validity.
- Explains that the source focuses on two different methods of treatment for patients with crohn's disease who are no longer responding appropriately to infliximab.
- Explains that the article discusses the best way in which infliximab can be used to gain a sustained response.
- Explains that the source has a sound methodology, which is explained and evaluated well, including useful graphs, tables, and flowcharts. it does not focus solely on how the infliximab is effective in treating the symptoms.
- Concludes that infliximab is very beneficial for patients with crohn's disease but predicts other drugs that are more easily administered may be developed.
- Explains that the article reviews the current treatment of inflammatory bowel disease with infliximab by examination of past clinical trials.
- Opines that this source is beneficial to this area of study as it gives a great detail of information on the treatment of crohn’s disease with infliximab, explaining how it works, and giving extensive examples of clinical trials as supportive evidence.
- Analyzes how the review article summarises some of the significant research undertaken previously and is well referenced for accessibility to these other clinical trials.
- Explains that a clinical trial compares two treatments for crohn's disease, infliximab and dalimumabe in terms of effectiveness and safety. both treatments seem to be effective and safe as long-term treatments.
- Compares the efficacy, mucosal healing, histological healing and safety of infliximab and adalimumabe, stating that the small research group in this clinical trial limits the information given.
1610 wordsRead More - The Medical Advances of World War Iexplanatory essayOne of the other notable important advances was the “Conquest of Polio” this disease usually caused paralysis in the people who contracted the virus. Back then there...
In this essay, the author
- Explains that there were many changes and advances in the field of medicine after world war i, including surgery, drugs, mental health, and phycology.
- Explains that most of these medical advances were a result and were an influence of world war i. alexander fleming discovered penicillin in 1928.
- Explains that fleming thought that penicillin could kill bacteria in the lab, but after failing to grow more, he gave up on the idea.
- Explains that scientists from great britain were intrigued by the possibilities of penicillin and produced enough to prove that it was a useable antibiotic.
- Explains that the "conquest of polio" was one of the notable advances in polio, which caused paralysis in people who contracted the virus.
- Explains that vaccinations against polio had been effectively developed in 1950, and had continued working. by 1994, the virus was mostly wiped out.
- Explains that organizations like who and unicef had set up vaccination programs to help immunize the world's children against diseases. there were also advances in the surgical medical field.
- Explains that neurosurgery and amputation were possible in the early 1900's, and that antibiotics helped widen the success and safety of surgery.
- Explains that the development of phycology was influenced by the medical problems that people had, that could not be explained by scientific or medical means.
- Explains that sigmund freud was intrigued by physiology and people who had medically unexplainable problems. he developed a useable hypnosis technique called the talking cure.
- Explains that the study and use of phycology based theories, proved useful for treating people with mental illnesses and medically unexplained issues.
- Explains that the world wars, world war i and ii have influenced many medical advances and changes in a good way. without these new medical and physiological advancements and studies help us understand what is going on in our minds and help people with mental issues.
652 wordsRead More - Clostridium Tetanus: Life-Threatening Diseaseexplanatory essayJalak Patel Course: Microbiology Prof: Ms. A Champa Nov 12, 2015 Clostridium Tetanus Tetanus is a life-threatening disease, associated with a type of bacterial that infection to nervous system, called Clostridium tetani. Its common name is lockjaw; symptom of the disease is stiffness and tightening of the jaw muscles. Tetanus is found in soil, animal feces, tetanus is spread by the spores entering the body through injury or wound. They can’t grow in the presence of oxygen, so they try to penetrate deep in the wound where oxygen supply is less.
In this essay, the author
- Explains that clostridium tetanus is a life-threatening disease that causes stiffness and tightening of the jaw muscles. it is spread by the spores entering the body through injury or wound.
- Explains that tetanus symptoms begin with mild spasms, lockjaw; affect neck, back, abdominal muscle, fever, swallowing difficulty. a 77-year-old woman was admitted to the hospital due to massive hematemesis.
- Narrates the case of a 7-year-old of kakaonde tribe, seen at american church mission in solwezi, zambia.
- Explains that tetanus is diagnosed by physical examination and medical history. it is treated by antibiotics, bed rest with dim light and stable temperature, breathing treatment, wound care, and vaccinations.
726 wordsRead More